Summary:
Click image to enlargeLocal doctors are conducting a clinical research study to test the safety and effectiveness of an investigational drug for treatment of liver fibrosis in adults with NASH.
Qualified Participants Must:
• Be 18-75 years old
• Have diagnosis of NASH
• Have evidence of stage 3 liver fibrosis
• Be willing and able to understand and sign written informed consent
Qualified Participants May Receive:
Qualified participants may receive all study-related care and study drug or placebo at no cost. Compensation may be available for participation as well.